Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
$0.057
+0.42%
(+0.00024) 1D
May 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
$0.06
High
$0.06
Low
$0.06
Mkt. cap
24.06M
Avg. vol.
269.75K
Volume
120.50K
52-wk high
$0.10
52-wk low
$0.04
EPS
-$0.01
Beta
0.75
Shares outstanding
420.28M
No. of employees
6
News stories
From sources across the web
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersKnoxville, Tennessee, United States
SectorPharmaceutical industry
Websiteprovectusbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
278.63K
57.48K
-
-
Cost of goods sold
380.66K
858.90K
323.22K
248.94K
Cost of revenue
380.66K
858.90K
323.22K
248.94K
Research and development expenses
-
-
13.64K
13.64K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
874.88K
874.18K
831.08K
761.24K
Operating expense
874.88K
874.18K
844.72K
774.88K
Total operating expenses
1.26M
1.73M
1.17M
1.02M
Operating income
-976.92K
-1.68M
-1.17M
-1.02M
Other non operating income
-
-
-
-
EBT including unusual items
-1.16M
-1.85M
-1.32M
-1.17M
EBT excluding unusual items
-1.04M
-1.73M
-1.22M
-1.07M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.14M
-1.81M
-1.31M
-1.17M
Net profit margin
-409.19%
-3,156.61%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-63.66K
-51.35K
-48.02K
-47.32K
Net interest expenses
-63.66K
-51.35K
-48.02K
-47.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
-976.45K
-1.68M
-1.17M
-1.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer